company background image
688016 logo

Shanghai MicroPort Endovascular MedTech SHSE:688016 Stock Report

Last Price

CN¥182.71

Market Cap

CN¥15.1b

7D

-0.6%

1Y

-1.2%

Updated

05 Apr, 2024

Data

Company Financials +

Shanghai MicroPort Endovascular MedTech Co., Ltd.

SHSE:688016 Stock Report

Market Cap: CN¥15.1b

Shanghai MicroPort Endovascular MedTech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai MicroPort Endovascular MedTech
Historical stock prices
Current Share PriceCN¥182.71
52 Week HighCN¥210.30
52 Week LowCN¥147.01
Beta0.33
1 Month Change-1.77%
3 Month Change0.088%
1 Year Change-1.24%
3 Year Change-37.02%
5 Year Changen/a
Change since IPO15.42%

Recent News & Updates

Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Mar 25
Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Recent updates

Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Mar 25
Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Shareholder Returns

688016CN Medical EquipmentCN Market
7D-0.6%0.9%1.7%
1Y-1.2%-18.2%-15.8%

Rendite im Vergleich zur Industrie: 688016 übertraf die Branche CN Medical Equipment , die im vergangenen Jahr eine Rendite von -20.5 erzielte.

Rendite vs. Markt: 688016 übertraf den Markt CN, der im vergangenen Jahr eine Rendite von -22 erzielte.

Price Volatility

Is 688016's price volatile compared to industry and market?
688016 volatility
688016 Average Weekly Movement6.3%
Medical Equipment Industry Average Movement7.6%
Market Average Movement8.3%
10% most volatile stocks in CN Market11.6%
10% least volatile stocks in CN Market5.2%

Stabiler Aktienkurs: 688016 hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: 688016Die wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

About the Company

FoundedEmployeesCEOWebsite
2012908Qing Zhuhttps://www.endovastec.com

Shanghai MicroPort Endovascular MedTech Co., Ltd. beschäftigt sich mit der Forschung und Entwicklung, der Herstellung und dem Verkauf von medizinischen Geräten für die Aorta und die peripheren Gefäße in China und international. Zu den Produkten des Unternehmens gehören Stentgraft-Systeme für thorakale Aortenaneurysmen und abdominale Aortenaneurysmen, Aortendissektionen, perkutane transluminale Angioplastie und Ballonkatheter sowie Zubehör wie Ballonaufblaskatheter.

Shanghai MicroPort Endovascular MedTech Co., Ltd. Fundamentals Summary

How do Shanghai MicroPort Endovascular MedTech's earnings and revenue compare to its market cap?
688016 fundamental statistics
Market capCN¥15.11b
Earnings (TTM)CN¥492.43m
Revenue (TTM)CN¥1.19b

30.7x

P/E Ratio

12.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688016 income statement (TTM)
RevenueCN¥1.19b
Cost of RevenueCN¥285.93m
Gross ProfitCN¥901.27m
Other ExpensesCN¥408.84m
EarningsCN¥492.43m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)5.95
Gross Margin75.92%
Net Profit Margin41.48%
Debt/Equity Ratio0%

How did 688016 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.